论文部分内容阅读
目的:评价复方阿嗪米特肠溶片用于慢性胆囊炎与胆结石患者的临床疗效。方法:选取2013年3月—2014年5月间收治的慢性胆囊炎与胆结石患者100例,将其分为慢性胆囊炎组和胆结石组各组50例;所有患者均给予复方阿嗪米特肠溶片治疗,评价所有患者治疗后的临床疗效。结果:治疗后慢性胆囊炎组患者总有效率为88.00%,胆结石组患者的总有效率为90.00%,两组患者总有效率经比较其差异无统计学意义(P>0.05);慢性胆囊炎组患者用药后腹胀症状的积分值为(0.88±0.10)分,显著低于用药之前的积分值为(2.74±0.12)分,胆结石组患者用药后的积分值为(0.86±0.12)分显著低于用药前为(2.73±0.11)分(P<0.05)。结论:慢性胆囊炎与胆结石患者给予复方阿嗪米特治疗,可以有效改善患者腹胀症状,加快消化功能恢复,从而提高患者生活质量,该治疗方法安全可靠、无严重不良反应。
Objective: To evaluate the clinical efficacy of compound azintamide enteric-coated tablets in patients with chronic cholecystitis and gallstones. Methods: One hundred patients with chronic cholecystitis and gallstones who were admitted to our hospital from March 2013 to May 2014 were selected and divided into 50 cases of chronic cholecystitis group and gallstone group. All patients were given compound azamet Special enteric treatment, evaluation of all patients after treatment of clinical efficacy. Results: The total effective rate of patients with chronic cholecystitis was 88.00% and the total effective rate of patients with gallstones was 90.00%. There was no significant difference in the total effective rate between the two groups (P> 0.05) The score of bloating symptom after treatment was (0.88 ± 0.10) points in inflammatory group, which was significantly lower than that before treatment (2.74 ± 0.12), and (0.86 ± 0.12) points in patients with gallstone after treatment Which was significantly lower than that before treatment (2.73 ± 0.11) (P <0.05). Conclusion: Patients with chronic cholecystitis and gallstones are treated with compound azinamazole, which can effectively improve the symptoms of abdominal distension, accelerate the recovery of digestive function, and improve the quality of life of patients. The treatment is safe and reliable without serious adverse reactions.